Skip to main content
Lipigon Pharmaceuticals AB logo

Lipigon Pharmaceuticals AB — Investor Relations & Filings

Ticker · LPGO ISIN · SE0015382072 LEI · 549300XPO40YR12SLY87 ST Professional, scientific and technical activities
Filings indexed 0 across all filing types
Latest filing no filings yet
Country SE Sweden
Listing ST LPGO

About Lipigon Pharmaceuticals AB

https://lipigon.se/

Lipigon Pharmaceuticals is a clinical-stage company specializing in lipid biology, focused on developing novel therapeutics for diseases related to lipid disorders and cardio-metabolic risk factors. The company's lead drug candidate, Lipisense®, is in clinical development for lowering blood triglyceride levels. Lipisense® utilizes a unique mechanism of action to address high blood fats, which are a significant risk factor for cardiovascular disease. The company's pipeline is founded on extensive research in blood lipid regulation, aiming to provide new treatment options for patients with conditions such as severe hypertriglyceridemia and other lipid-related disorders where a significant unmet medical need exists.

Recent filings

No filings indexed yet

We are still gathering filings for Lipigon Pharmaceuticals AB. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.